Stephen Kirk
About Stephen Kirk
Stephen Kirk serves as the Senior Toxicology Manager at KalVista Pharmaceuticals, Inc. in Salisbury, United Kingdom, where he has worked since 2019. He possesses extensive expertise in biotechnology-derived pharmaceuticals and vaccines, with a background that includes roles at Covance and Aptuit.
Work at KalVista Pharmaceuticals
Stephen Kirk has been serving as the Senior Toxicology Manager at KalVista Pharmaceuticals, Inc. since 2019. His role in Salisbury, United Kingdom, involves overseeing toxicology assessments related to drug development. His expertise contributes to the safety evaluation of biotechnology-derived pharmaceuticals and vaccines, ensuring compliance with industry standards.
Previous Experience in Toxicology
Before joining KalVista Pharmaceuticals, Stephen Kirk held significant positions in the field of toxicology. He worked at Covance as the Global Lead for Immunotoxicology from 2015 to 2017. Prior to that, he served as Study Director in Toxicology at Aptuit from 2006 to 2009. His experience spans various aspects of non-clinical safety assessment.
Education and Expertise
Stephen Kirk earned a Bachelor of Science with Honours in Immunology from the University of Glasgow, where he studied from 1989 to 1993. He furthered his education with a Postgraduate Certificate in Biopharmaceutical Development from the University of Leeds, completed between 2017 and 2019. Additionally, he holds a Certificate in Business Studies from The Open University.
Current Role at Covance
In addition to his position at KalVista Pharmaceuticals, Stephen Kirk has been working at Covance as a Principal Investigator since 2017. His responsibilities in Harrogate, United Kingdom, include leading studies that assess the safety of pharmaceutical products, leveraging his extensive background in toxicology and immunology.
Ongoing Education
Stephen Kirk is currently pursuing further education at Harrogate College, focusing on Education and Training, where he is achieving a BTEC Level 3 qualification since 2015. This commitment to continuous learning reflects his dedication to professional development in the field.